Clinical Trial Update: Effect of a High Density Formula on Growth and Safety in Congenital Heart Disease Infants [NA]

View source ↗

Summary

Clinical trial completed evaluating the growth and safety effects of a high-density formula in infants with congenital heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• High Density Formula (High-density infant formula)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Congenital Heart Disease | NA | Status: COMPLETED